what's more, the share price will rise towards the mid year in anticipation of the result of the Rett study. The current lag would appear to be due to a general sell-off (even much-fancied ADO is down) and the interest in a number of other biotechs at present. Nowabouts would seem quite a good time to buy, particularly given the lack of day trader interest at present.
what's more, the share price will rise towards the mid year in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.88 |
Change
-0.140(1.00%) |
Mkt cap ! $1.727B | |||
| Open | High | Low | Value | Volume |
| $13.90 | $14.21 | $13.64 | $4.590M | 329.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600 | $13.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.96 | 2894 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |